BIOTECH MADNESS

[jdoe]

[ QUOTE ]
[ QUOTE ]


Some people know the results of the study, call options are off the chart.



[/ QUOTE ]

Do you really think the call options reflect the results of the study, i.e. that top employees are risking insider trading convictions to make some extra coin? Note that that employees likely already will cash in if the study is successful, they have options. But you think they'll risk prison time to make a little more?

[/ QUOTE ]

Employees of NFLD no

Doctors, nurses, and paramedics in Thirty-two Level 1 trauma centers throughout the U.S. that were a part of the study....I think maybe.

There is a big Chicago hedge fund all over this (NFLD is nearby)

you wil have to admit that the options are out of whack


>>Also you have some other risks that you aren't mentioning. One is that the FDA says the study was successful, but it wants to see a bigger study before approving the product for sale. Secondly is that it turns out the market for the product is not as large as estimated due to some issues that haven't surfaced yet.<<




[/ QUOTE ]

This is Phase III results to be reported this quarter, there is no Phase 4.



How could the market not be huge? We are talking about oxygenated synthetic blood. If the FDA comes back with approval on something like this with a 26 mill shares out.

What do you think a company like that would be worth?

To get this product to market will take a long time, if the FDA repots positive results NFLD takes off like a rocket, there will be bumps in the road i am sure.

jdoe